What Do Recent Landmark, Cardiovascular Outcome Trials Evaluating PCSK9 Inhibition in the Diabetic Patient Population Teach Us? How Effective Are PCSK9 Inhibitors in the Diabetic Population? Overall? How Safe?

What Do Recent Landmark, Cardiovascular Outcome Trials Evaluating PCSK9 Inhibition in the Diabetic Patient Population Teach Us? How Effective Are PCSK9 Inhibitors in the Diabetic Population? Overall? How Safe?


Published

November 14, 2018

Created by

CMEducation Resources symposium